Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

[Magnetic resonance imaging findings of Chromophobe renal cell carcinoma].

Wang XK, Wang HY, Wang J, Wang YW, Wang Y, Tang YH, Ye HY.

Zhonghua Yi Xue Za Zhi. 2013 Apr 2;93(13):1016-9. Chinese.

PMID:
23886268
2.

[MR appearance of multifocal clear cell renal cell carcinoma].

Wang HY, Ye HY, Yuan J, Ma L, Zhang X, Tang YH.

Zhonghua Yi Xue Za Zhi. 2013 Jul 16;93(27):2161-3. Chinese.

PMID:
24284252
3.

Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.

Sun MR, Ngo L, Genega EM, Atkins MB, Finn ME, Rofsky NM, Pedrosa I.

Radiology. 2009 Mar;250(3):793-802. doi: 10.1148/radiol.2503080995.

PMID:
19244046
4.

Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.

Wehrli NE, Kim MJ, Matza BW, Melamed J, Taneja SS, Rosenkrantz AB.

AJR Am J Roentgenol. 2013 Dec;201(6):1260-7. doi: 10.2214/AJR.13.10673.

PMID:
24261365
5.

Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification.

Inci E, Hocaoglu E, Aydin S, Cimilli T.

Eur J Radiol. 2012 May;81(5):815-20. doi: 10.1016/j.ejrad.2011.02.024. Epub 2011 Mar 4.

PMID:
21377306
6.

Usefulness of diffusion-weighted imaging in the evaluation of renal masses.

Sandrasegaran K, Sundaram CP, Ramaswamy R, Akisik FM, Rydberg MP, Lin C, Aisen AM.

AJR Am J Roentgenol. 2010 Feb;194(2):438-45. doi: 10.2214/AJR.09.3024.

PMID:
20093607
7.

Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.

Goyal A, Sharma R, Bhalla AS, Gamanagatti S, Seth A, Iyer VK, Das P.

Acta Radiol. 2012 Apr 1;53(3):349-58. doi: 10.1258/ar.2011.110415.

PMID:
22496427
8.

Characteristic MRI findings of sarcomatoid renal cell carcinoma dedifferentiated from clear cell renal carcinoma: radiological-pathological correlation.

Takeuchi M, Urano M, Hara M, Fujiyoshi Y, Inagaki H, Shibamoto Y.

Clin Imaging. 2013 Sep-Oct;37(5):908-12. doi: 10.1016/j.clinimag.2013.04.010. Epub 2013 Jul 6.

PMID:
23834905
9.

The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases.

Zhang C, Li X, Hao H, Yu W, He Z, Zhou L.

BJU Int. 2012 Dec;110(11 Pt B):E481-5. doi: 10.1111/j.1464-410X.2012.11173.x. Epub 2012 Apr 30.

10.

[MR imaging features of different renal cell carcinoma subtypes].

Wu B, Peng WJ, Gu YJ, Yang TX, Jiang ZX, Zhang HL, Dai B, Ye DW, Kong YY, Du X.

Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):825-30. Chinese.

PMID:
19173827
11.

MRI features of renal oncocytoma and chromophobe renal cell carcinoma.

Rosenkrantz AB, Hindman N, Fitzgerald EF, Niver BE, Melamed J, Babb JS.

AJR Am J Roentgenol. 2010 Dec;195(6):W421-7. doi: 10.2214/AJR.10.4718.

PMID:
21098174
12.

[Clinical features on chromophobe renal cell carcinoma].

Wang ZH, DU LH, Hu ZQ, Chen XG, Zhao X, Wang SG, Zhuang QY, Ye ZQ.

Zhonghua Wai Ke Za Zhi. 2011 Apr 1;49(4):320-3. Chinese.

PMID:
21612697
13.

Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.

Wang H, Cheng L, Zhang X, Wang D, Guo A, Gao Y, Ye H.

Radiology. 2010 Oct;257(1):135-43. doi: 10.1148/radiol.10092396. Epub 2010 Aug 16.

PMID:
20713607
14.

[Comparison of MRI manifestations and histopathologic findings in pancreatic head carcinoma in vivo ex vivo].

Wang DQ, Zeng MS, Shi X, Ji Y, Jin DY, Lou WH, Chen CZ, Li RC, Shen JZ.

Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):347-51. Chinese.

PMID:
18953833
15.

Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.

Rosenkrantz AB, Niver BE, Fitzgerald EF, Babb JS, Chandarana H, Melamed J.

AJR Am J Roentgenol. 2010 Nov;195(5):W344-51. doi: 10.2214/AJR.10.4688.

PMID:
20966299
16.

[A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].

Liu R, Wang JH, Zhou KR, Yan FH, Yan ZP, Shen JZ, Tan YS, Cai Y.

Zhonghua Gan Zang Bing Za Zhi. 2005 Oct;13(10):754-8. Chinese.

PMID:
16248948
17.

Predicting the histology of small renal masses using preoperative dynamic contrast-enhanced magnetic resonance imaging.

Kim JH, Bae JH, Lee KW, Kim ME, Park SJ, Park JY.

Urology. 2012 Oct;80(4):872-6. doi: 10.1016/j.urology.2012.06.001. Epub 2012 Jul 31.

PMID:
22854134
18.

Small renal masses: assessment of lesion characterization and vascularity on dynamic contrast-enhanced MR imaging with fat suppression.

Scialpi M, Di Maggio A, Midiri M, Loperfido A, Angelelli G, Rotondo A.

AJR Am J Roentgenol. 2000 Sep;175(3):751-7.

PMID:
10954462
19.

[Characterization and staging of renal tumors: significance of MRI diagnostics].

Kalinka A, Gerlach A, Arlart IP, Günes N, Hauser TK, Würstlin S, Bosse A.

Rofo. 2006 Mar;178(3):298-305. German.

PMID:
16508837
20.

Small renal tumors: correlation of clinical and pathological features with tumor size.

Pahernik S, Ziegler S, Roos F, Melchior SW, Thüroff JW.

J Urol. 2007 Aug;178(2):414-7; discussion 416-7. Epub 2007 Jun 11.

PMID:
17561161

Supplemental Content

Support Center